Van Laar ES - Search Results

1

ATM-dependent CHK2 activation induced by anticancer agent, irofulven.

Wang J, Wiltshire T, Wang Y, Mikell C, Burks J, Cunningham C, Van Laar ES, Waters SJ, Reed E, Wang W. Wang J, et al. Among authors: van laar es. J Biol Chem. 2004 Sep 17;279(38):39584-92. doi: 10.1074/jbc.M400015200. Epub 2004 Jul 20. J Biol Chem. 2004. PMID: 15269203 Free article.

2

Activity of irofulven against human pancreatic carcinoma cell lines in vitro and in vivo.

Van Laar ES, Roth S, Weitman S, MacDonald JR, Waters SJ. Van Laar ES, et al. Anticancer Res. 2004 Jan-Feb;24(1):59-65. Anticancer Res. 2004. PMID: 15015576 Free article.

3

Antitumor activity of irofulven monotherapy and in combination with mitoxantrone or docetaxel against human prostate cancer models.

Van Laar ES, Weitman S, MacDonald JR, Waters SJ. Van Laar ES, et al. Prostate. 2004 Apr 1;59(1):22-32. doi: 10.1002/pros.10351. Prostate. 2004. PMID: 14991863

4

Antitumor activity of irofulven against human ovarian cancer cell lines, human tumor colony-forming units, and xenografts.

van Laar ES, Izbicka E, Weitman S, Medina-Gundrum L, Macdonald JR, Waters SJ. van Laar ES, et al. Int J Gynecol Cancer. 2004 Sep-Oct;14(5):824-31. doi: 10.1111/j.1048-891X.2004.014515.x. Int J Gynecol Cancer. 2004. PMID: 15361190

5

Ovarian tumor growth regression using a combination of vascular targeting agents anginex or topomimetic 0118 and the chemotherapeutic irofulven.

Dings RP, Van Laar ES, Webber J, Zhang Y, Griffin RJ, Waters SJ, MacDonald JR, Mayo KH. Dings RP, et al. Among authors: van laar es. Cancer Lett. 2008 Jul 8;265(2):270-80. doi: 10.1016/j.canlet.2008.02.048. Epub 2008 Apr 1. Cancer Lett. 2008. PMID: 18378392 Free PMC article.

6

Inhibiting tumor growth by targeting tumor vasculature with galectin-1 antagonist anginex conjugated to the cytotoxic acylfulvene, 6-hydroxylpropylacylfulvene.

Dings RP, Van Laar ES, Loren M, Webber J, Zhang Y, Waters SJ, Macdonald JR, Mayo KH. Dings RP, et al. Among authors: van laar es. Bioconjug Chem. 2010 Jan;21(1):20-7. doi: 10.1021/bc900287y. Bioconjug Chem. 2010. PMID: 20020769

7

Response.

Van Laar ES, Desai JM, Jatoi A. Van Laar ES, et al. Support Care Cancer. 2015 Aug;23(8):2213. doi: 10.1007/s00520-015-2753-2. Epub 2015 May 15. Support Care Cancer. 2015. PMID: 25975674 No abstract available.

8

Professional educational needs for chemotherapy-induced nausea and vomiting (CINV): multinational survey results from 2388 health care providers.

Van Laar ES, Desai JM, Jatoi A. Van Laar ES, et al. Support Care Cancer. 2015 Jan;23(1):151-7. doi: 10.1007/s00520-014-2325-x. Support Care Cancer. 2015. PMID: 25015057 Free PMC article.

9

Improving shared decision-making in chronic lymphocytic leukemia through multidisciplinary education.

Rocque GB, Williams CP, Halilova KI, Borate U, Jackson BE, Van Laar ES, Pisu M, Butler TW, Davis RS, Mehta A, Knight SJ, Safford MM. Rocque GB, et al. Among authors: van laar es. Transl Behav Med. 2018 Mar 1;8(2):175-182. doi: 10.1093/tbm/ibx034. Transl Behav Med. 2018. PMID: 29390159

10

Assessment of ATRX expression in patients with myelodysplastic syndromes treated with decitabine.

Steensma DP, Porcher JC, Litzow MR, Hogan WJ, Arora S, Van Laar ES. Steensma DP, et al. Among authors: van laar es. Leuk Res. 2009 Jul;33(7):e81-2. doi: 10.1016/j.leukres.2008.11.030. Epub 2009 Jan 20. Leuk Res. 2009. PMID: 19157545 Free PMC article. Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters